THERE is an estimated 1 billion adults worldwide who have hypertension, and the number of individuals with cerebro-cardiovascular diseases caused by hypertension already accounts for 17.5 million.
In the Philippines, the latest Presyon study released in 2021 by the Philippine Heart Association showed that the country saw a progressive rise of high-blood pressure among Filipinos, where the prevalence of hypertension climbed to 37 percent this year.
Cerebro-cardiovascular diseases are the leading cause of death globally, and even when patients manage to survive after an event, risks of becoming bedridden or serious side effects remain high. Not only patients, but also their families can be impacted mentally and financially, and the level of their health-related quality of life (QOL) is jeopardized.
This is the reason why in the Philippines, OMRON has collaborated with the Philippine Society of Hypertension to help educate Filipinos on how to prevent high blood pressure and heart disease by switching to a healthy lifestyle and monitor blood pressure regularly at home.
With the mission of “helping realize healthy and comfortable lives for people around the world,” OMRON Healthcare unveiled its “Going for ZERO” vision–achieve zero cerebro-cardiovascular events–for its cardiovascular business in 2015, and has expanded the business domains focusing mainly on home blood pressure monitors.
OMRON Healthcare Co., Ltd., whose head office is located in Muko, Kyoto, Japan, and headed by its President and CEO: Isao Ogino, has also announced that cumulative global sales of home-use blood pressure monitors has reached 300 million units.
It was in 1973 when OMRON released its first electronic blood pressure monitor and now, OMRON blood pressure monitors are available in more than 110 countries/regions across the world, including the Philippines.
“We are celebrating this remarkable milestone by strengthening our commitment to serving our customers here in the Philippines even better. We are working hard on forging more partnerships and making our products more accessible so that OMRON can help more Filipino families in maintaining good heart health from home,” said Yusuke Kato, General Manager for OMRON Asia Pacific Pte. Ltd – Philippine Branch (Healthcare Division).
Since the release of the first device, it took OMRON 36 years to achieve cumulative global sales of 100 million units in 2009. In the 2010s, people became more conscious of managing their own health, and at the same time, the number of patients with lifestyle-related diseases dramatically increased on a global scale. Just around the same time, the guidelines for home treatment of hypertension were officially established by leading medical societies, and a new behavioral pattern – monitoring blood pressure at home – became more popular.
As a result, it took only 7 years to sell the next 100 million units. Ever since, OMRON has expanded across global markets consistently, accommodating the increasing demand of blood pressure monitors not only in America, China, and Europe, but also in developing countries such as the Philippines, Indonesia, India and Brazil, and it took only 5 years to reach the 300 million-unit sales this year.
Now, taking this opportunity as a milestone for the new chapter, it will continue to identify the market demands and user needs, while responding to them swiftly with innovative solutions.
Furthermore, the service business, such as the development of health-management apps for smartphones and a remote patient monitoring service, will be accelerated. OMRON Healthcare will support both home health managements and healthcare professional’s patients treatment with its devices and services to help realize healthy and comfortable lives for people around the world.
To celebrate this significant milestone, OMRON also launched a new global website that talks about OMRON’s history and challenges, along with its future vision and goal of achieving zero cerebro-cardiovascular events. The website contains OMRON’s journey, which contains a history of home blood pressure monitors, measurement accuracy and design philosophy, its challenge regarding promotion of remote patient monitoring service globally, development of Artificial Intelligence (AI) technology for risk preventions, evolving blood pressure management, and the expansion of the business into a cerebro-cardiovascular domain; and valuable academic research on blood pressure.
The website can be accessed via https://healthcare.omron.com/public/going-for-zero/300-million/.